Dr. Patton co-founded InCarda (previously Pleiades Cardio-Therapeutics, Inc.) along with Dr. Schuler, Dr. Marcus and Mr. Rangachari in 2009. He is an entrepreneur in the field of drug delivery, particularly pulmonary and protein delivery. He is also the Founder and CEO of Dance Pharmaceuticals, Inc.
Prior to founding Dance in 2009, Dr. Patton was co-founder of Inhale Therapeutics (now Nektar), where he served as Head of Research and CSO from 1990-2008. At Inhale/Nektar he initiated and helped lead the development and FDA approval of the first inhaled insulin product. He also led drug delivery at Genentech (1985-1990).
Dr. Patton has been a tenured professor at the University of Georgia. He received his Ph.D. in biology from the University of California, San Diego, and held post-doctoral positions in biomedicine at Harvard Medical School and the University of Lund, Sweden. He serves on scientific advisory boards for Penn State University, Scripps Institution of Oceanography and Aridis Pharmaceuticals as well as the executive boards of Dance, Halozyme and Activaero. He has written over 100 publications and holds over 40 patents.